Pablo Avilés
PharmaMar (Spain)(ES)
Publications by Year
Research Areas
Synthesis and Biological Activity, Cancer Treatment and Pharmacology, Microbial Natural Products and Biosynthesis, Chemical Synthesis and Analysis, Medical Image Segmentation Techniques
Most-Cited Works
- → Lurbinectedin (PM01183), a New DNA Minor Groove Binder, Inhibits Growth of Orthotopic Primary Graft of Cisplatin-Resistant Epithelial Ovarian Cancer(2012)96 cited
- → Activities of Sordarins in Experimental Models of Candidiasis, Aspergillosis, and Pneumocystosis(2000)39 cited
- → In Vitro Pharmacodynamic Parameters of Sordarin Derivatives in Comparison with Those of Marketed Compounds against Pneumocystis carinii Isolated from Rats(2000)35 cited
- → Computer-assisted enhanced volumetric segmentation magnetic resonance imaging data using a mixture of artificial neural networks(2003)28 cited
- → Targeting eEF1A reprograms translation and uncovers broad-spectrum antivirals against cap or m6A protein synthesis routes(2025)17 cited
- → Monitoring acute inflammatory processes in mouse muscle by MR imaging and spectroscopy: a comparison with pathological results(2002)16 cited
- → Levels of active tyrosine kinase receptor determine the tumor response to Zalypsis(2014)13 cited
- → PM534, an Optimized Target-Protein Interaction Strategy through the Colchicine Site of Tubulin(2024)11 cited
- → Factores de riesgo de la ventilación mecánica prolongada de niños con cirugía cardíaca(2008)11 cited
- The novel compound PM00104 exhibits significant in vivo activity against breast tumors. PM00104 exhibits significant in vivo activity against breast tumors(2005)